ASSESSMENT OF THE N-TERMINAL COLLAGEN III-TYPE PROPEPTIDE IN PATIENTS WITH CHRONIC HEART FAILURE AND METABOLIC SYNDROME

Development and progress of chronic heart failure (CHF) are faster in obesity, lipid and carbohydrate metabolism disorders. The liver presentation of metabolic syndrome (MS) is the non-alcoholic fatty liver disease (NAFLD). Comorbidity of NAFLD and cardiovascular diseases leads to increase of cardio...

Full description

Saved in:
Bibliographic Details
Main Authors: O. M. Drapkina, E. V. Zyatenkova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2015-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/280
Tags: Add Tag
No Tags, Be the first to tag this record!